JP2017524704A5 - - Google Patents

Download PDF

Info

Publication number
JP2017524704A5
JP2017524704A5 JP2017504421A JP2017504421A JP2017524704A5 JP 2017524704 A5 JP2017524704 A5 JP 2017524704A5 JP 2017504421 A JP2017504421 A JP 2017504421A JP 2017504421 A JP2017504421 A JP 2017504421A JP 2017524704 A5 JP2017524704 A5 JP 2017524704A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
substituted
acceptable salt
compound according
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017504421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017524704A (ja
JP6568929B2 (ja
Filing date
Publication date
Priority claimed from CN201410398333.4A external-priority patent/CN105439946B/zh
Application filed filed Critical
Publication of JP2017524704A publication Critical patent/JP2017524704A/ja
Publication of JP2017524704A5 publication Critical patent/JP2017524704A5/ja
Application granted granted Critical
Publication of JP6568929B2 publication Critical patent/JP6568929B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017504421A 2014-08-13 2015-08-11 カルボン酸化合物、その製造方法および使用 Active JP6568929B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201410398333.4A CN105439946B (zh) 2014-08-13 2014-08-13 羧酸化合物及其制备方法和用途
CN201410398333.4 2014-08-13
PCT/CN2015/086605 WO2016023460A1 (zh) 2014-08-13 2015-08-11 羧酸化合物及其制备方法和用途

Publications (3)

Publication Number Publication Date
JP2017524704A JP2017524704A (ja) 2017-08-31
JP2017524704A5 true JP2017524704A5 (https=) 2018-09-13
JP6568929B2 JP6568929B2 (ja) 2019-08-28

Family

ID=55303876

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017504421A Active JP6568929B2 (ja) 2014-08-13 2015-08-11 カルボン酸化合物、その製造方法および使用

Country Status (11)

Country Link
US (2) US9809580B2 (https=)
EP (1) EP3181557B1 (https=)
JP (1) JP6568929B2 (https=)
KR (1) KR102474640B1 (https=)
CN (2) CN105439946B (https=)
AU (1) AU2015303597B2 (https=)
CA (1) CA2956045C (https=)
ES (1) ES2942259T3 (https=)
IL (1) IL250524B (https=)
NZ (1) NZ729037A (https=)
WO (1) WO2016023460A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105439946B (zh) * 2014-08-13 2018-02-02 益方生物科技(上海)有限公司 羧酸化合物及其制备方法和用途
JP6898330B2 (ja) 2015-12-28 2021-07-07 シャンハイ フォチョン ファーマシューティカル カンパニー リミテッド インドリジン誘導体、組成物、及び使用方法
CN105884807A (zh) * 2016-04-26 2016-08-24 昆药集团股份有限公司 硼酸频那醇酯衍生物的制备方法、硫代乙酸盐化合物的制备方法
CN106748987B (zh) * 2016-11-18 2019-05-31 昆药集团股份有限公司 2-((3-(4-氰基萘-1-基)吡啶-4-基)硫基)-2-甲基丙酸钠盐的晶型
AR113270A1 (es) * 2017-10-04 2020-03-11 Japan Tobacco Inc Compuesto de heteroarilo con contenido de nitrógeno y su uso farmacéutico
CN108084153A (zh) * 2017-12-20 2018-05-29 广东赛烽医药科技有限公司 吡啶基硫代乙酸化合物、组合物及其应用
CN108069940B (zh) * 2017-12-20 2021-04-30 广东赛烽医药科技有限公司 硫代乙酸化合物、组合物及其应用
CN108440397B (zh) * 2018-03-06 2020-06-05 南方医科大学 3-(萘-1-甲基取代)吡啶衍生物及其合成方法和应用
WO2019183835A1 (en) 2018-03-28 2019-10-03 Inventisbio Shanghai Ltd. Novel salt forms of urat-1 inhibitors
CN108484494B (zh) * 2018-06-15 2021-07-30 沈阳药科大学 2-氧代-1,2-二氢吡啶-4-甲酸类化合物
CN111943957B (zh) * 2019-05-17 2023-01-06 中国医学科学院药物研究所 喹啉甲酰胺类化合物及其制备方法和用途
CN113493407B (zh) * 2020-04-03 2025-01-28 中国医学科学院药物研究所 一种吡啶类化合物及其制法和药物用途
EP4301749A1 (en) * 2021-03-01 2024-01-10 Orion Corporation Solid forms of a 4h-pyran-4-one structured cyp11a1 inhibitor
AR124985A1 (es) * 2021-03-01 2023-05-24 Orion Corp Nuevas formas de sal de un inhibidor de cyp11a1 estructurado en 4h-piran-4-ona
CN113979931B (zh) * 2021-10-08 2023-06-13 南方医科大学 一种吡啶3-胺衍生物及其制备方法和应用
CN116715633B (zh) * 2022-04-27 2025-08-12 杭州新元素药业股份有限公司 可用于降尿酸的化合物
CN121816339A (zh) * 2023-09-19 2026-04-07 广东横琴新创益生物医药有限公司 一种六元并五元稠环衍生物及其制备方法和应用
WO2025060752A1 (zh) * 2023-09-19 2025-03-27 湘北威尔曼制药股份有限公司 一种硫醚衍生物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19541146A1 (de) * 1995-10-25 1997-04-30 Schering Ag Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren
SE0301010D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
FR2903984B1 (fr) * 2006-07-24 2008-10-03 Genfit Sa Derives d'imidazolones substitues, preparation et utilisations
ES2470329T3 (es) * 2009-08-28 2014-06-23 Daiichi Sankyo Company, Limited Derivado del ácido 3-(biariloxi) priopi�nico
AR081930A1 (es) * 2010-06-16 2012-10-31 Ardea Biosciences Inc Compuestos de tioacetato
TWI499412B (zh) * 2010-06-16 2015-09-11 亞德生化公司 苯基硫乙酸酯組合物及其使用方法
MY180138A (en) * 2011-11-03 2020-11-23 Ardea Biosciences Inc 3,4-di-substituted pyridine compound,methods of using and compositions comprising the same
US20150291514A1 (en) * 2012-01-04 2015-10-15 Pfizer Limted N-Aminosulfonyl Benzamides
WO2013158422A1 (en) * 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
CN105439946B (zh) * 2014-08-13 2018-02-02 益方生物科技(上海)有限公司 羧酸化合物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2017524704A5 (https=)
JP2012527475A5 (https=)
MX2022014312A (es) Inhibidores de sarcomero cardiaco.
RU2018120242A (ru) Хинолиновые соединения, способы их получения и их применения в качестве лекарственного средства, ингибирующего транспортер уратов
HRP20140391T1 (hr) Spojevi i pripravci tioacetata, te postupci uporabe
EP4660303A3 (en) Pcsk9 antagonist compounds
JP2016518437A5 (https=)
RU2013119129A (ru) Органические соединения
WO2010059239A3 (en) Lactate salt of 4-(6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
JP2012525393A5 (https=)
RU2013121788A (ru) Ингибиторы репликации вич
JP2016528276A (ja) プラーク退縮を促進するための組成物及び治療法
JOP20230035A1 (ar) مثبطات apol1 وطرق استخدامها
JP2017523219A5 (https=)
JP2013528650A5 (https=)
JP2016540759A5 (https=)
JP2012526769A5 (https=)
JP2017531673A5 (https=)
JPWO2023195529A5 (https=)
JP2021042207A (ja) トロンボキサン受容体アンタゴニスト
JP2019065009A5 (https=)
JP2017515899A5 (https=)
EP4591940A3 (en) Deoxy- cytidine derivatives for use in cancer therapies
JP2019507167A5 (https=)
JP2010505869A5 (https=)